Profile
Trends
Explore the Research Trends
Research Network
Explore the Expert Network
Publications
-
1.
2013Erin B. Dickerson; Kevin Marley; Wade Edris; Jeffrey W. Tyner; Vidya Schalk; Valerie MacDonald; Marc Loriaux; Brian J. Druker; Stuart C. Helfand
Imatinib and dasatinib inhibit hemangiosarcoma and implicate PDGFR-β and Src in tumor growth
Translational Oncology. 2013;6(2):158-168. -
2.
2013Daniel Bottomly; Beth Wilmot; Jeffrey W. Tyner; Christopher A. Eide; Marc M. Loriaux; Brian J. Druker; Shannon K. McWeeney
HitWalker: Variant prioritization for personalized functional cancer genomics
Bioinformatics. 2013;29(4):509-510. -
3.
2013Stephen E. Spurgeon; Greg Coffey; Luke B. Fletcher; Russell Burke; Jeffrey W. Tyner; Brian J. Druker; Andreas Betz; Francis DeGuzman; Yvonne Pak; Dale Baker; et al.
Journal of Pharmacology and Experimental Therapeutics. 2013;344(2):378-387.
Similar Experts
- Publications
- 47










- 182










- 73










- 234










Journals
-
Publications
-
81
-
28
-
20
-
15
-
13
Grants
-
1.
Druker Brian J.
Accelerating target identification and validation in leukemia: Integrating siRNA-
9/30/2009 - 8/31/2011
Sponsor: NATIONAL CANCER INSTITUTE
Funding: $ 999,728.00
-
2.
Druker Brian J.
9/1/2005 - 8/31/2006
Sponsor: NATIONAL CANCER INSTITUTE
Funding: $ 10,000.00
-
3.
Druker Brian J.
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
7/9/1999 - 6/30/2004
Sponsor: NATIONAL CANCER INSTITUTE
Funding: $ 235,980.00
Institutional Network
-
Internal OrganizationsShared Pub.
-
59









-
47









-
8









-
8









-
7









-
5









-
External OrganizationsShared Pub.
-
38
-
36
-
25
-
19
-
18
-
17


Export
